Related Experiment Video
Updated: Jan 7, 2026
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
Hemophagocytic lymphohistiocytosis is characterized by tissue factor-driven coagulopathy, endothelial injury, and
Tanvi Y P Verma1, Ivo M B Francischetti1
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome marked by defective cytotoxic lymphocyte function. While its immunologic features are recognized, the contribution of immunothrombosis is less defined. We analyzed plasma from 12 HLH patients with viral, lymphomatous, and autoimmune etiologies. Hallmark features included hyperferritinemia, cytopenias, hypertriglyceridemia, elevated sIL-2Rα, and acute-phase reactants. Cytokine profiling showed high IL-6, IL-8, IL-10, TNF-α, CRP, and IL-18, with variable IFN-γ. Coagulation studies revealed compensated DIC, elevated FVIIa/antithrombin complexes, and microparticle-bound tissue factor, implying in extrinsic pathway activation. Thrombomodulin shedding and reduced Protein S indicated impaired protein C anticoagulant function. The fibrinolytic system is impaired based on high levels of PAI-1/tPA, and complement activation with consumption of C3. Endothelial dysfunction was evidenced by elevated sVCAM-1, sICAM-1, angiopoietin-2, and decreased ADAMTS13. Elevated plasma SVEP-1 and immunohistochemical evidence of pS6 supported mTORC1 activation in histiocytes. In conclusion, HLH is more accurately described as a "cytokine storm" with pronounced immunothrombosis. The interplay between these 2 processes through multiple, redundant, and reciprocal mechanisms may represent a unifying pathway in HLH pathogenesis and reveal novel therapeutic targets.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome marked by defective cytotoxic lymphocyte function. While its immunologic features are recognized, the contribution of immunothrombosis is less defined. We analyzed plasma from 12 HLH patients with viral, lymphomatous, and autoimmune etiologies. Hallmark features included hyperferritinemia, cytopenias, hypertriglyceridemia, elevated sIL-2Rα, and acute-phase reactants. Cytokine profiling showed high IL-6, IL-8, IL-10, TNF-α, CRP, and IL-18, with variable IFN-γ. Coagulation studies revealed compensated DIC, elevated FVIIa/antithrombin complexes, and microparticle-bound tissue factor, implying in extrinsic pathway activation. Thrombomodulin shedding and reduced Protein S indicated impaired protein C anticoagulant function. The fibrinolytic system is impaired based on high levels of PAI-1/tPA, and complement activation with consumption of C3. Endothelial dysfunction was evidenced by elevated sVCAM-1, sICAM-1, angiopoietin-2, and decreased ADAMTS13. Elevated plasma SVEP-1 and immunohistochemical evidence of pS6 supported mTORC1 activation in histiocytes. In conclusion, HLH is more accurately described as a "cytokine storm" with pronounced immunothrombosis. The interplay between these 2 processes through multiple, redundant, and reciprocal mechanisms may represent a unifying pathway in HLH pathogenesis and reveal novel therapeutic targets.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:30Venous Thrombosis I: Introduction
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:05Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
01:09Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...